Shrooms Online Changed Stage 4 Colon Cancer Patient’s View

Counting down the time you have left is terrifying, especially after a cancer diagnosis. Some might tell you you’ll live, while others count your remaining days. You…what would you do to truly live? 

Meet Thomas Hartle, a 56-year-old battling stage 4 colon cancer. To change his view on death, he turned to psychedelic-assisted therapy. This experience profoundly reshaped his perception of dying. Since 2016, he’s been using this medical intervention to manage the distress that comes with his terminal diagnosis. He initially had difficulty accessing the compound, but with the availability of shrooms online, cancer patients can now easily obtain them.

Key Takeaways:

  • Thomas Hartle found relief from depression and came to terms with his mortality through psilocybin-assisted therapy after antidepressants had left him feeling emotionally numb.
  • Psilocybin’s impact on Hartle’s mental health lasted for a year before he took another dose.
  • The patient takes a capsule, listens to curated music, wears an eye mask, and undergoes a 6 to 8-hour session with a therapist present throughout the treatment process.

How Long Can Someone With Stage 4 Colon Cancer Live?

Stage 4 colon cancer is the most known advanced form of the disease. It has spread from the colon to other body parts, such as the liver, lungs, or lymph nodes. The 5-year survival rate is around 13%, highlighting the severity of this condition.

Diagnosing requires multiple tests, including:

  • Physical examination
  • Blood tests
  • Colonoscopy to view the inside of the rectum and colon.
  • Biopsy for tissue sample analysis.
  • Imaging tests like CT, PET, MRI scans, and chest X-rays to check for the disease’s spread.

Patient Profile – A Journey Through Diagnosis and Beyond

Patients like Thomas Hartle didn’t feel comfortable with antidepressants. While they eased his anxiety, they also dulled his positive emotions like happiness and love. Out of medical consideration and curiosity, his interest in psychedelics starts to grow.

  • Full Name: Thomas Hartle
  • Age: 56
  • Background: A father of two, a professional in the finance industry, and an avid outdoorsman.
  • Initial Diagnosis: Diagnosed with Stage 4 colon ailment after experiencing persistent abdominal pain and changes in bowel habits.
  • Emotional State: Upon diagnosis, the patient faced overwhelming fear and despair. Grappled with the grim prognosis and the potential impact on his family.

Hartle’s Story

Antidepressants dulled both Hartle’s anxiety and his positive emotions, so he decided to explore alternatives. After reading a Johns Hopkins study showing that 80% of cancer-related patients experienced reduced depression and anxiety with psychedelics, Hartle became interested in psychedelic treatment. 

Despite growing up with anti-drug beliefs, Hartle pursued this treatment. He found profound comfort and relief in his first session. He accessed it through a Section 56 exemption for end-of-life distress or approved studies.

He was the first Canadian to get psychedelic-assisted intervention in 2020 and found profound relief from end-of-life distress. He ingested seven grams of magic mushrooms under medical supervision. Later on, he experienced “ego death” and a transformative shift in his view of death. 

Going Through Mental Treatment

Hartle experienced revelations or “aha moments” during or after therapy. He explained, “You don’t always know what you’ll get out of a session. If you go in with expectations, you might set yourself up for disappointment. Sometimes, you won’t get what you expect, and you might receive something entirely different.”

Hartle shared that his sessions have had a cumulative effect, with each one leaving a longer-lasting impact. His second session occurred three months after his first experience with psilocybin, and his most recent session was a year ago.

Hartle initially feared death as the end of consciousness but now sees it as a transition. His sessions have had a lasting positive impact – he has become more compassionate and empathetic. He advocates for broader access to this therapeutic rehabilitation, as he believes it can benefit those with severe anxiety and depression.

What Will Happen When Psilocybin Meets Modern Therapy?

Psilocybin-assisted therapy isn’t about recreational use, like taking magic mushrooms at a festival. It’s a clinical approach backed by research from major academic centers.

Psilocybin is a hallucinogenic substance from certain mushroom species. At specific doses, it can cause hallucinations. Some people also report deep insights and mystical experiences during these “trips.”

History of Psilocybin Therapy

TimeEvent
Pre-Columbian EraPsychedelic mushrooms were part of Mesoamerican civilizations (Olmec, Maya, Aztecs) rituals.
1950sWestern society “discovered” hallucinogens in the 1950s through a traditional healer in Oaxaca.
1958Swiss chemist Albert Hoffman identified shroom’s active ingredient from the Psilocybe mexicana mushroom.
1970Sudden halt in psychedelic studies.
1990sResearch on psychedelics resumed after a decades-long pause.
2000s-2010sIncreased research on psilocybin’s potential for OCD, end-of-life distress, and addiction treatments.
2016-PresentClinical trials on psychedelics for major depressive disorder and cancer-related anxiety marked a turning point.

What Happens During Psilocybin Therapy?

  1. Preparation: The patient and therapist build a relationship, establishing trust to ensure the patient feels comfortable and supported during the session.
  2. Session: In a specially designed room, the patient lies down and takes a dose of psychedelic in capsule form. They listen to a curated music playlist and wear an eye mask to focus inward. The session lasts 6 to 8 hours, with a therapist present throughout.
  3. Integration: Patient discusses their experiences with the therapist to help them process and integrate the insights gained.

What Shroom Products Can I Use for Therapeutic Use?

Various product types are available, with its own set of advantages and drawbacks. Choose the one that aligns best with your therapeutic goals.

  1. Dried Mushrooms: Whole or sliced Psilocybe cubensis mushrooms. They offer a traditional use and customizable dosing but have a bitter taste and require careful dosage management.
  2. Capsules: Pre-measured shroom powder in capsule form. They are convenient and provide controlled dosage but have a slower onset and are less traditional.
  3. Edibles: Chocolates and gummies infused with psychedelic substances. They are tasty and easy to consume.
ProductBlue Magnolia RustWonder – Chocolate Bar – Milk Chocolate – Golden TeacherGround Sounds – Microdose Capsules – Super Freak
TypeHighly potent dried mushroomsChocolate bar infused with shroomsMicrodose capsules with adaptogens 
BenefitsCognitive improvement, a potential treatment for depression and anxiety. Contains ergothioneine and hericystin.Increased creativity, reduced anxiety, improved mood, and ego reset.Reduces stress, improves mood, boosts the immune system, and contains adaptogens like Reishi, Ashwagandha, and Chaga.
EffectsHallucinogenic effects with a dreamy, spiritual experience. Effects start 30 minutes to 2 hoursModerate to mega doses with varied effects, from philosophical discussions to intense experiences.Reduces anxiety and stress and improves overall mental state. Effects vary with dosage.
Usage InstructionsNot recommended for beginners. Best used with guidance.Consume 6 pieces for moderate, and 18 for mega doses. Add every 90 minutes.Available in 50mg, 100mg, or 250mg doses. Used on a scheduled basis.

Psilocybin’s Role in Modern Cancer Care

Clinical studies show that psilocybin can reduce anxiety, depression, and fear of death in terminally ill patients. Stories like Hartle’s demonstrate how psychedelic medical intervention can offer more than just symptom relief. It can profoundly change perspectives on end-of-life issues.

Access to this substance isn’t straightforward. Only a few programs are available, and getting into them can require time and money. Online options like Zoomies Canada offer a more affordable and accessible alternative.

Frequently Asked Questions

How much psilocybin do patients ingest for therapy sessions?

It starts low and is adjusted based on the individual’s response. In clinical trials, a single 25 mg dose of psychedelics, combined with psychological support, has been effective in reducing depression in treatment-resistant patients.

How does shroom active compound reduce depression?

There are multiple theories on how the active compound reduces the symptoms, but the most common is the involvement of the DMN. It reduces activity in the brain’s default mode network (DMN), the brain’s “inner narrator” that criticizes and diminishes self-worth. By dampening these negative thoughts, it helps quiet the critical inner voice.

It also allows neurons to connect in new ways, much like they did in childhood. This activation helps the brain function differently than usual – it fosters a renewed sense of hope.

It evokes profound psychological experiences, such as a connection with a higher power or a feeling of interconnectedness with all things. This can diminish loneliness and reduce shame, blame, and guilt about the past.

How long does psilocybin manage depression and anxiety?

The effectiveness can vary due to differences in dosage, the therapist’s approach, and individual responses. In studies where patients received only a single dose, some individuals showed improvements that lasted up to eight years. For most people with chronic depression, the benefits diminish after four to five months.

Leave a Reply

Your email address will not be published. Required fields are marked *